Neuroscience Journal / 2015 / Article / Tab 1

Research Article

Change in Motor and Nonmotor Symptoms Severity in a “Real-Life” Cohort of Subjects with Parkinson’s Disease

Table 1

Comparison of drug treatment between initial and follow-up visits.

Initial visitFollow-up value

Use of levodopa40 (75.5%)45 (84.9%)0.063
Levodopa dose (mg)447.8 ± 399.6487.5 ± 348.80.419
Use of dopamine agonists31 (41.5%)28 (52.8%)0.181
Use of MAOi4 (7.5%)8 (15.7%)0.133
DA-LEDD (mg)88.2 ± 130.3160.3 ± 1860.009
Total LEDD556.8 ± 410.4676.3 ± 380.50.015
Use of antidepressants12 (22.6%)13 (24.5%)>0.99
Surgery (bilateral DBS)0%2 (3.8%)

Total (percentage). Mean ± standard deviation. LEDD: levodopa equivalent daily dose. DA-LEDD: dopamine agonists-levodopa equivalent daily dose. MAOi: monoamine oxidase inhibitor. DBS: deep brain stimulation.